Determination That LASIX (Furosemide) Oral Solution, 10 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
By Health, Drug Administration, Human Services Department, Food · Oct 8, 2026, 11:00 PM CDT
The Food and Drug Administration (FDA, Agency, or we) has determined that LASIX (furosemide) oral solution, 10 milligrams (mg)/ milliliter (mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to this drug product, and it will allow FDA to con
Excerpt shown under fair-use limits. Full text remains with the original publisher.
People in this coverage
Explore their history and attributable record. Being mentioned does not imply endorsement.
Layer 1 · Claims & fact checks
AI analysisLayer 3 · Reporting analysis
AI analysisAuthority AppealThe statement relies on the FDA’s authority to establish credibility and reassure readers about the product’s status.
Clarity of OutcomeThe language explicitly outlines the regulatory consequence, emphasizing continuity of approval.
Context
AI analysisMissing context
The announcement does not explain why the determination was needed, what prior rumors or actions prompted the statement, or any details about the regulatory history of the product.
Important context
The FDA’s statement clarifies that the product remains approved and that ANDAs can continue to be approved provided they meet legal and regulatory requirements.
Opinion vs. reporting
AI analysisThe text is purely factual reporting of an FDA determination; it contains no opinion or editorial commentary.